Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 12 holding rows worth $241,282,412.

Accession
0001591986-23-000006
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 12 entries on the cover page, a total value of $241,282,412 stated on the cover page (in dollars after the unit check, H1), rows summing to $241,282,412 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVESCO QQQ TR46090E103COM220,000$70,604,600dollars as filedput
BLUEPRINT MEDICINES CORP09627Y109COM622,829$28,021,077dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM1,018,474$25,869,240dollars as filed
MERUS N VN5749R100COM1,225,109$22,542,006dollars as filed
KYMERA THERAPEUTICS INC501575104COM601,325$17,817,260dollars as filed
ARVINAS INC04335A105COM628,941$17,182,668dollars as filed
REGENXBIO INC75901B107COM831,014$15,714,475dollars as filed
UNIQURE NVN90064101SHS637,526$12,839,774dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share242,848$9,169,940dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR24,000$8,941,920dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS1,312,233$8,135,845dollars as filed
PIERIS PHARMACEUTICALS INC720795103COM4,552,876$4,443,607dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001591986-23-000006this filing2023-05-15acceptance time not in the bulk data set